The Aplio i600 ultrasound scanner from Canon Medical Systems USA has received U.S. Food and Drug Administration (FDA) clearance.
First demonstrated at RSNA 2017, Aplio i600 is an entry-level system designed to provide high-quality imaging with easy-to-use workflow and performance features, according to the company.
Canon is highlighting Aplio i600's intuitive ergonomics, which the company believes will help boost productivity during routine and complex exams with the scanner's iSense design, which makes it easy for clinicians to adjust the console to virtually any scanning position.
The scanner also sports an image-guided user interface that visually guides clinicians through exams while simplifying system operation and improving efficiency. Aplio i600 also features Canon's iPerformance imaging technology, which reduces clutter, strengthens signal, and improves visualization.
In addition, Aplio i600 uses the same transducers as Canon's Aplio Platinum series of scanners, making migration to the new system easier.
The company is highlighting the system at this week's American Institute of Ultrasound in Medicine (AIUM) meeting in New York City.
![Examples of ultrasound findings and techniques. (A) Images in a 39-year-old male patient with a mass in the left thigh. The mass is heterogeneous on the B-mode US image (compared with the patient in D) and showed increased microvascularity (superb microvascular imaging [SMI]) and shear-wave elastography (SWE) values. Undifferentiated pleomorphic sarcoma was diagnosed at biopsy (with pleomorphic rhabdomyosarcoma in surgical specimen). (B) Images in an 18-year-old male patient with a mass in the left leg. The mass is hypoechoic on the B-mode image, with no other findings suggestive of malignancy. The lesion is in contact with the cortex of the tibia, which is slightly irregular. CT revealed a doubtful anteromedial tibial erosion. The microvascular study demonstrated high vascularization, suggestive of malignancy. Periosteal Ewing sarcoma was diagnosed with both histologic and immunohistochemical confirmation. (C) Images in a 69-year-old female patient with a lump growing on the outside of the left leg. Multiple SWE examinations were performed (please note the high values obtained in the measurements, whereas the color map highlights the stiffness relative to adjacent tissues). SMI showed areas of increased vascularization to target for sampling. Undifferentiated spindle cell sarcoma was diagnosed at biopsy, with residual leiomyosarcoma in the surgical specimen after neoadjuvant therapy. (D) Images in a 56-year-old female patient with a mass in the right thigh. The mass is heterogeneous at both B-mode ultrasound (similar to patient A) and MRI (coronal T2-weighted spectral attenuated inversion recovery [SPAIR]; T1-weighted pre-contrast and postcontrast imaging), which even shows uptake after the administration of paramagnetic contrast material, which is traditionally suggestive of malignancy. Low values at SMI and elastography are suggestive of benignity. Spindle cell lipoma was diagnosed at biopsy, with atypical spindle cell lipomatous tumor in the surgical specimen.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/08/images-radiol250278fig2.APCFLSvX6p.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
